Related Experiment Video
Updated: Aug 23, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
PML regulates p53 stability by sequestering Mdm2 to the nucleolus
Rosa Bernardi1, Pier Paolo Scaglioni, Stephan Bergmann
1Cancer Biology and Genetics Program, Department of Pathology and Medicine, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abstract:
The promyelocytic leukaemia (PML) tumour-suppressor protein potentiates p53 function by regulating post-translational modifications, such as CBP-dependent acetylation and Chk2-dependent phosphorylation, in the PML-Nuclear Body (NB). PML was recently shown to interact with the p53 ubiquitin-ligase Mdm2 (refs 4-6); however, the mechanism by which PML regulates Mdm2 remains unclear. Here, we show that PML enhances p53 stability by sequestering Mdm2 to the nucleolus. We found that after DNA damage, PML and Mdm2 accumulate in the nucleolus in an Arf-independent manner. In addition, we found that the nucleolar localization of PML is dependent on ATR activation and phosphorylation of PML by ATR. Notably, in Pml(-/-) cells, sequestration of Mdm2 to the nucleolus was impaired, as well as p53 stabilization and the induction of apoptosis. Furthermore, we demonstrate that PML physically associates with the nucleolar protein L11, and that L11 knockdown impairs the ability of PML to localize to nucleoli after DNA damage. These findings demonstrate an unexpected role of PML in the nucleolar network for tumour suppression.
Insights
Promyelocytic leukaemia (PML) protein enhances p53 stability by moving Mdm2 to the nucleolus, a key mechanism for tumor suppression. This process, dependent on ATR and L11, is crucial for p53 stabilization and apoptosis induction after DNA damage.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The promyelocytic leukaemia (PML) protein is a tumor suppressor that enhances p53 function through post-translational modifications within PML-Nuclear Bodies.
- PML interacts with Mdm2, a p53 ubiquitin ligase, but the regulatory mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which PML regulates Mdm2 and its impact on p53 stability and tumor suppression.
Main Methods:
- Investigated PML-Mdm2 interaction and localization after DNA damage using cell models.
- Utilized techniques including nucleolar sequestration assays, ATR activation studies, and L11 knockdown experiments.
- Assessed p53 stabilization, apoptosis induction, and nucleolar localization of PML and Mdm2 in wild-type and Pml(-/-) cells.
Main Results:
- PML enhances p53 stability by sequestering Mdm2 to the nucleolus in an Arf-independent manner after DNA damage.
- Nucleolar localization of PML is dependent on ATR activation and subsequent phosphorylation.
- Impaired Mdm2 sequestration, p53 stabilization, and apoptosis were observed in Pml(-/-) cells.
- PML associates with nucleolar protein L11, which is essential for PML's nucleolar localization post-DNA damage.
Conclusions:
- PML plays a critical role in tumor suppression through a novel mechanism involving Mdm2 sequestration to the nucleolus.
- This nucleolar pathway, regulated by ATR and L11, is vital for maintaining p53 stability and inducing apoptosis.
- Highlights an unexpected function of PML within the nucleolar network for cancer prevention.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Regulation of Nuclear Protein Sorting
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

